These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38439599)

  • 1. Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases.
    Berni Canani R; Caminati M; Carucci L; Eguiluz-Gracia I
    Allergy; 2024 Jun; 79(6):1485-1500. PubMed ID: 38439599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The origins of allergy from a systems approach.
    Krempski JW; Dant C; Nadeau KC
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):507-516. PubMed ID: 32702411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation.
    Zhu TH; Zhu TR; Tran KA; Sivamani RK; Shi VY
    Br J Dermatol; 2018 Sep; 179(3):570-581. PubMed ID: 29761483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influences on allergic mechanisms through gut, lung, and skin microbiome exposures.
    Kemter AM; Nagler CR
    J Clin Invest; 2019 Feb; 129(4):1483-1492. PubMed ID: 30830878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outside-in hypothesis revisited: The role of microbial, epithelial, and immune interactions.
    Sugita K; Soyka MB; Wawrzyniak P; Rinaldi AO; Mitamura Y; Akdis M; Akdis CA
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):517-527. PubMed ID: 32454094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases.
    Sugita K; Kabashima K
    J Leukoc Biol; 2020 May; 107(5):749-762. PubMed ID: 32108379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease.
    Celebi Sozener Z; Ozdel Ozturk B; Cerci P; Turk M; Gorgulu Akin B; Akdis M; Altiner S; Ozbey U; Ogulur I; Mitamura Y; Yilmaz I; Nadeau K; Ozdemir C; Mungan D; Akdis CA
    Allergy; 2022 May; 77(5):1418-1449. PubMed ID: 35108405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of the Keystone Symposium "Origins of allergic disease: Microbial, epithelial and immune interactions," March 24-27, Tahoe City, California.
    DeKruyff RH; Zhang W; Nadeau KC; Leung DYM; Wills-Karp M
    J Allergy Clin Immunol; 2020 Apr; 145(4):1072-1081.e1. PubMed ID: 31926182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-1 Mediated Tight Junction Dysfunction as a Contributor to Atopic March.
    Xia Y; Cao H; Zheng J; Chen L
    Front Immunol; 2022; 13():927465. PubMed ID: 35844593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial barriers in allergy and asthma.
    Hellings PW; Steelant B
    J Allergy Clin Immunol; 2020 Jun; 145(6):1499-1509. PubMed ID: 32507228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental factors in epithelial barrier dysfunction.
    Celebi Sözener Z; Cevhertas L; Nadeau K; Akdis M; Akdis CA
    J Allergy Clin Immunol; 2020 Jun; 145(6):1517-1528. PubMed ID: 32507229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the Immune System Mechanisms using Probiotic Bacteria in Allergic Diseases: Focus on Allergic Retinitis and Food Allergies.
    Forouhandeh H; Soofiyani SR; Hosseini K; Beirami SM; Ahangari H; Moammer Y; Ebrahimzadeh S; Nejad MK; Farjami A; Khodaiefar F; Tarhriz V
    Recent Adv Inflamm Allergy Drug Discov; 2024; 18(1):11-26. PubMed ID: 37842889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous barrier dysfunction in allergic diseases.
    Leung DYM; Berdyshev E; Goleva E
    J Allergy Clin Immunol; 2020 Jun; 145(6):1485-1497. PubMed ID: 32507227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between barrier impairment and skin microbiota in atopic dermatitis from a global perspective: Unmet needs and open questions.
    Darlenski R; Kozyrskyj AL; Fluhr JW; Caraballo L
    J Allergy Clin Immunol; 2021 Dec; 148(6):1387-1393. PubMed ID: 34688495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?
    Akdis CA
    Nat Rev Immunol; 2021 Nov; 21(11):739-751. PubMed ID: 33846604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of TSLP in allergic disease and its role as a potential therapeutic target.
    Cianferoni A; Spergel J
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1463-74. PubMed ID: 25340427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the surface: Skin microbial exposure contributes to allergic disease.
    DeVore SB; Gonzalez T; Sherenian MG; Herr AB; Khurana Hershey GK
    Ann Allergy Asthma Immunol; 2020 Dec; 125(6):628-638. PubMed ID: 32853786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial barrier repair and prevention of allergy.
    Goleva E; Berdyshev E; Leung DY
    J Clin Invest; 2019 Apr; 129(4):1463-1474. PubMed ID: 30776025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yu-Ping-Feng-San ameliorates recurrent allergic inflammation of atopic dermatitis by repairing tight junction defects of the epithelial barrier.
    Zheng J; Wang X; Tao Y; Wang Y; Yu X; Liu H; Ji L; Bao K; Wang C; Jia Z; Hong M
    Phytomedicine; 2019 Feb; 54():214-223. PubMed ID: 30668371
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.